New TB Vaccine Undergoes Trial

Government Will Regulate Sale of Anti-TB Drugs
  • Serum, one of the world’s leading vaccine manufacturers, has signed a contract with Hanover-based Vakzine Projekt Management GmbH and secured the license to manufacture a new TB vaccine. It was originally developed in Germany.
  • It will be tested in over 2,000 adults in an ambitious trial to be undertaken by Indian Council of Medical Research (ICMR), National Institutes of Health and others.